Align Wealth Management’s Merck MRK Stock Holding History

Align Wealth Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$172	Buy	+2	New	+$204	﹤0.01%	211

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Align Wealth Management's MRK Position: Q4 2022 in Review

Align Wealth Management opened a new position in Merck (MRK) in Q4 2022: 2 shares worth $172. The stake represents ﹤0.01% of the portfolio and ranks #211 among its holdings.

3,238 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

Align Wealth Management held 2 shares of Merck worth $172 as of Q4 2022.
Merck was a new Align Wealth Management position in Q4 2022.
Merck made up ﹤0.01% of Align Wealth Management's portfolio in Q4 2022, its #211 holding.
3,238 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Align Wealth Management's 13F filing for Q4 2022, filed 9 Jan 2023.